Top Markets
#1 Pons Pons +59.34%
#2 Purr Purr +54.08%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 Non-Playable Coin Non-Playable Coin +34.40%
#5 TENDIES TENDIES +28.49%
#6 Cash Cat Cash Cat +27.00%
#7 Morpho Morpho +24.89%
#8 Kinetiq Kinetiq +24.27%
#9 StonkBroker StonkBroker +22.49%
#10 ApeX ApeX +22.18%
Coin of the day
Pons Pons
Setări
Limbă
ROMâNă
Monedă
USD
Temă
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rang în acțiuni #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Preț acțiune
$2.22
Ultima sincronizare: 2026-08-21
Capitalizare de piață
$117.70M
Schimbare (1 zi)
2.69%
Schimbare (1 an)
17.26%
Țară
SE
Tranzacționează SynAct Pharma AB (SYNACT)

Categorie

Healthcare
Raport P/S pentru SynAct Pharma AB (SYNACT)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor SynAct Pharma AB, raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru SynAct Pharma AB din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH